Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
This study has been completed.
Eastern Cooperative Oncology Group
Information provided by:
National Cancer Institute (NCI)
First received: November 1, 1999
Last updated: February 6, 2009
Last verified: July 2004
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||No date given|
Wadler S, Levy D, Frederickson HL, Falkson CI, Wang Y, Weller E, Burk R, Ho G, Kadish AS; Eastern Cooperative Oncology Group. A phase II trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. Eastern Cooperative Oncology Group study E1E96. Gynecol Oncol. 2004 Mar;92(3):957-64.